Eyer wins WSA 2020

Eyer wins WSA 2020

Phelcom Eyer is one winner of the renowned World Summit Awards (WSA) 2020, in the category Health & Well-Being. The global award recognizes the digital innovation that contributes to achieve the United Nations Sustainable Development Goals (UN SDGS). On the whole, this edition included 40 solutions from 26 countries.

“We are honored to receive such an importante prize. Such recognition shows that our values and efforts to change the reality of visual health worldwide are aligned to the goals of other people and institutions, such as the UN and the WSA”, states Phelcom CEO, José Augusto Stuchi.

Modern technologies – combined with a social cause and intelligent content – not only solve problems but also increase the quality, the access to information and inclusion. “The challenges this year show, more than ever, how digital means can offer progress and solutions. WSA 2020 winners presented a wonderful showcase of purpose-driven innovation and entrepreneurship”, point out the WSA president, Peter A. Bruck.

Stuchi explains that the goal of developing Eyer is to change the reality of eye healthcare worldwide. Currently, 80% of blindness cases could be avoided, according to the World Health Organization (WHO).

“We may cause a great impact with our solution, because we have a great social appeal to this global reality”. Receiving an award from a renowned institution of the size of WSA, linked to the UN Sustainable Development Goals, makes us very happy, because it shows we are aligned to the institutions we have as mirrors. In addition, it confirms the importance and impact that our solution may cause in the world”, he remarks.

 

Selection

 

To take part in the award, Phelcom subscribed Eyer in the Brazilian stage, in the Health & Well-Being category. There are eight categories, each with a single winner. In August, the startup won the local selection and qualified to the world phase, where there are five winners per category. “Competitors are evaluated by an international jury in terms of sustainability, goal, technological and strategic refinement”, says Bruck.

Phelcom will be honored in WSA Global Congress, that occurs from March 22 to 24, 2021, completely online.

 

Phelcom Eyer

 

Phelcom Eyer is the first smartdevice on the market that enables to quickly carry out fundus exams with cloud storage.

The equipment works coupled to a smartphone and is non-mydriatic. It has the same quality of a tabletop retinograph. Equipment portability allows it to be easily transported to community task forces in different locations.

Integrated to the cloud, it makes data automatically available on the EyerCloud online platform. So, a doctor located anywhere in the world can diagnose.

Eyer aims to help combat visual impairment and global blindness, which affect 2,2 billion people, according to the World Health Organization (WHO). From this total, 1 billion cases would be avoidable or remediable. That is, they occurred due to lack of access to the necessary care, such as examinations and treatments.

 

About WSA

 

WSA was founded in 2003 by Austria as part of the UN World Summit on Information Society. The global initiative recognizes that local digital content contributes to achieve the United Nations Sustainable Development Goals (UN SDG).

WSA reaches digital entrepreneurs in 182 countries countries around the world and provides a single platform for everyone interested in goal-driven digital innovation. In close cooperation to the United Nation agencies and strategically aligned to the UN SDGs, WSA is a worldwide recognized quality seal for digital innovation.

Phelcom Eyer hits 100,000 exam mark

Phelcom Eyer hits 100,000 exam mark

Startup Phelcom Technologies has a lot to celebrate. Its first product, Phelcom Eyer handheld fundus camera, has carried out 100,000 exams. The equipment was released to market only 1 year and 4 months ago.

Anterior segment and color retinography exams are the most performed at present. “An estimated 850 professionals utilize the technology and there are about 90.000 patients registered to our online platform, the Eyer Cloud”, says Phelcom co-founder and CEO, José Augusto Stuchi.

200 thousand exams are expected to be produced by half of 2021.

Phelcom Eyer

Phelcom Eyer is state-of-the-art in portable retinography for prevention and diagnose of eye related diseases.

The device works attached to a smartphone and performs high-quality retina exams in few minutes, without need for pupil dilation. Integrated to cloud, it automatically provides data in the EyerCloud online platform. Therefore, it enables a doctor to diagnose from anywhere over the world.

Eyer aims to help tackling vision impairment and blindness worldwide, which affect 2,2 billion people, according to the World Health Organization. One billion out of those cases would be avoidable or remediable. That is to say, they occurred due to lack of access to proper care, such as exams and treatments.

Phelcom Eyer

 

Eyer Cloud

Eyer Cloud is an online platform integrated to Phelcom Eyer handheld fundus camera, which enables storage and management of patient exams. All data the equipment captures are automatically synchronized to the system, allowing a completely safe upload to the cloud.

More than having a backup of all the information in a safe server, the user has all data organized within a user-friendly functional intuitive interface. Furthermore, platform access is available through the device or via cellphone, tablet and computer.

“It is possible to quickly and easily register all the patients to the system, view high-quality and large size images on screen and, then, make a report”, explains Phelcom co-founder and COO, Flávio Pascoal Vieira.

Any healthcare professional – not necessarily an expert – is able to carry out the exam in the field after a brief training. For that, the physician can liberate specific accesses for each team member. For example, a technician may only register patients and capture images. The external specialist, in its turn, is able to generate diagnoses without accessing patient’s personal information, thus keeping their privacy.

Among the main functionalities are the possibility of separating patient information with more than one clinic and visualize them in the same platform and doctor profile; locating patients by name or exam date; and creating report templates from pre-made models available in the system.

In case there is no internet connection for the exam, the device stores the images and uploads them to the cloud as soon as a connection is available.

Phelcom Eyer

Phelcom Technologies

Phelcom Technologies is a startup that brings technology and healthcare together, headquartered in São Carlos, SP, Brazil. It manufactures connected wearable handheld devices, aiming to democratize access to healthcare, offering better services, with a compact equipment, to more people.

In order to develop its first product, the startup received funding from Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP), a foundation for scientific research and from Samsumg Creative Economy Promotion Program as well. It also counts on support from the incubators Supera Parque and Eretz.bio, the latter from Israeli Hospital Albert Einstein.

 

Indigenous reserves receive medical care in Mato Grosso

Indigenous reserves receive medical care in Mato Grosso

In January this year, ophthalmologist Korn Malerbi boarded an expedition towards a special destination: taking free medical care to three indigenous reserves in the State of Mato Grosso. “I was invited to join a team of doctors who already takes periodical actions in these locations”, tells Malerbi.

The group consists of physicians of the Department of Social Medicine, from the USP Medical School (Ribeirão Preto), and the Department of Endocrinology, from Paulista School of Medicine, Unifesp.

The expedition counted on four specialists in the following areas: ophthalmology, endocrinology and preventive and social medicine.

Malerbi explains that the reserves Sangradouro, Meruri and São Marcos present high rates of diabetes mellitus. “This disease may trigger various other health conditions, such as diabetic retinopathy. In case it is not detected and adequately treated in time, this ophthalmological alteration may lead to blindness”, he clarifies.

 

 

 

In order to identify the disease and other possible disorders, the doctor carried out retinography and applanation tonometry. 193 indigenous people altogether were evaluated, from Xavante and Bororo communities, during eight days of work.

More than diabetic retinopathy, exams found cases of cataract.

Eyer

 

The ophthalmologist utilized Phelcom Eyer handheld fundus camera to perform the exams.

The equipment is state-of-the-art in portable retinography for prevention and diagnose of eye-related diseases.

It works attached to a smartphone and performs high-quality retina exams in few minutes, without need of pupil dilation. Synchronized to cloud, it automatically provides data to the online platform EyerCloud, so that they can be analyzed by a specialist anywhere over the world. That is, it enables remote diagnostic.

“It was a great experience with the equipment, mainly because of its portability and ease of access”, evaluates Malerbi.

He reminds of his involvement in other projects with the fundus camera, also for diagnosing diabetic retinopathy. “I believe Eyer to be very relevant for this kind of action, representing an important alternative for mapping and tracking diseases in populations from remote areas”, he finishes.

 

Eyer: Phelcom reaches 200 equipment produced

Eyer: Phelcom reaches 200 equipment produced

Startup Phelcom Technologies has just manufactured its 200th Eyer, an innovative technology that enables carrying out retina exams through a smartphone. The handheld fundus camera was released in April. “Eyer had remarkable market acceptance. This way, we’ve reached our production goal way before planned”, reveals Phelcom’s co-founder and CEO, José Augusto Stuchi. Device distribution is queued.

The equipment is already present in all regions of Brazil, Including institutions as USP, Unifesp, Albert Einstein Hospital, the Holy House of São Pauo, Sadalla Amin Ghanem Eye Hospital, Prevent Senior and Opty Group, inter alia.

More than 15 thousand exams have been conducted so far. Expectancy for 2020 is that the technology will be used in retina exams for more than 100 thousand people.

Eyer has embedded artificial intelligence (AI) and works through mobile technology and telemedicine. Exams data are available in EyerCloud, a cloud system that enable remote diagnostic. “Portability and low cost make Eyer one of the improvement tools for eye health access to more people. Mainly in remote communities and regions with deficient healthcare infrastructure. Only 15% of Brazilian cities offer ophthalmology services at present”, explains Phelcom’s co-founder and COO, Flávio Pascoal Vieira.

 

Phelcom Eyer

 

retinografia para neurologistas

 

The startup’s first product, Eyer, is a state-of-the art in portable retinography for prevention and diagnostic of eye related diseases.

The device works attached to a smartphone and performs high-quality retina exams in few minutes, without need for pupil dilation. Synchronized to cloud, it automatically provides data to the online platform EyerCloud, so that a specialist can analyze them anywhere over the world. That is, it enables remote diagnostic.

Eyer aims to help tackling vision impairment and blindness worldwide, which affect 2,2 billion people, according to the World Health Organization. One billion out of those cases would be avoidable or remediable. That is to say, they occurred due to lack of access for proper care, such as exams and treatments.

 

Phelcom Technologies

 

Phelcom Technologies is a startup that brings technology and healthcare together, headquartered in São Carlos, SP, Brazil. It manufactures connected wearable handheld devices, aiming to democratize access to healthcare, offering better services to more people, with a compact equipment.

In order to develop its first product, the startup received funding from Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP), a foundation for scientific research and from Samsumg Creative Economy Promotion Program as well. It also counts on support from the incubators Supera Parque and Eretz.bio, the latter from Israeli Hospital Albert Einstein.